About Abbott Laboratories
Abbott Laboratories (ABT) has been publicly traded since 1980, making it a 46-year-old public company. It operates in the Medical Devices industry within the Healthcare sector. The company is headquartered in Abbott Park, United States and employs approximately 115,000 people. With a market capitalization of $188 billion, ABT is a large established company.
Key Statistics
- Current Price
- $108.66
- Market Cap
- $188.82B
- 52-Week High
- $139.06
- 52-Week Low
- $105.27
- Sector
- Healthcare
- Industry
- Medical Devices
$1,000 Invested
Monthly Returns Heatmap
Annual Returns
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | -12.83% | $124.66 | $108.66 |
| 2025 | +12.87% | $110.45 | $124.66 |
| 2024 | +4.81% | $105.38 | $110.45 |
| 2023 | +2.26% | $103.05 | $105.38 |
| 2022 | -20.68% | $129.92 | $103.05 |
| 2021 | +30.53% | $99.53 | $129.92 |
| 2020 | +28.04% | $77.73 | $99.53 |
| 2019 | +22.08% | $63.67 | $77.73 |
| 2018 | +29.06% | $49.34 | $63.67 |
| 2017 | +52.03% | $32.45 | $49.34 |
| 2016 | -12.32% | $37.01 | $32.45 |
| 2015 | +1.87% | $36.33 | $37.01 |
| 2014 | +20.08% | $30.26 | $36.33 |
| 2013 | +23.96% | $24.41 | $30.26 |
| 2012 | +20.30% | $20.29 | $24.41 |
| 2011 | +21.78% | $16.66 | $20.29 |
| 2010 | -8.27% | $18.16 | $16.66 |
| 2009 | +4.58% | $17.37 | $18.16 |
| 2008 | -2.49% | $17.81 | $17.37 |
| 2007 | +18.04% | $15.09 | $17.81 |
| 2006 | +26.86% | $11.89 | $15.09 |
| 2005 | -13.48% | $13.75 | $11.89 |
| 2004 | +17.80% | $11.67 | $13.75 |
| 2003 | +19.27% | $9.78 | $11.67 |
| 2002 | -26.73% | $13.35 | $9.78 |
| 2001 | +17.08% | $11.41 | $13.35 |
| 2000 | +35.84% | $8.40 | $11.41 |
| 1999 | -24.79% | $11.16 | $8.40 |
| 1998 | +51.84% | $7.35 | $11.16 |
| 1997 | +31.97% | $5.57 | $7.35 |
| 1996 | +24.56% | $4.47 | $5.57 |
| 1995 | +30.45% | $3.43 | $4.47 |
| 1994 | +12.98% | $3.04 | $3.43 |
| 1993 | +0.02% | $3.03 | $3.04 |
| 1992 | -10.10% | $3.38 | $3.03 |
| 1991 | +56.10% | $2.16 | $3.38 |
| 1990 | +35.23% | $1.60 | $2.16 |
| 1989 | +44.71% | $1.10 | $1.60 |
| 1988 | +2.21% | $1.08 | $1.10 |
| 1987 | +7.04% | $1.01 | $1.08 |
| 1986 | +36.06% | $0.74 | $1.01 |
| 1985 | +68.21% | $0.44 | $0.74 |
| 1984 | -5.16% | $0.47 | $0.44 |
| 1983 | +19.29% | $0.39 | $0.47 |
| 1982 | +43.52% | $0.27 | $0.39 |
| 1981 | -4.42% | $0.28 | $0.27 |
Valuation
ABT currently trades at a trailing P/E ratio of 29.0, which is considered high relative to the broader market. The forward P/E of 17.3 suggests analysts expect earnings to be lower in the coming year. The price-to-book ratio stands at 3.6. The price-to-sales ratio is 4.2.
Dividends
Abbott Laboratories pays a dividend to shareholders with a current yield of 2.33%. This translates to $2.52 per share annually. The payout ratio of 63% indicates moderate dividend coverage.
Risk & Volatility
ABT has a beta of 0.74, indicating it is less volatile than the overall market. The stock's 52-week range is $105.27 to $139.06, and it currently trades near its 52-week low.
Analyst Ratings
Based on 25 analyst opinions, ABT has a consensus "buy" rating. The average price target of $132.64 suggests 22.8% upside from current levels.
Frequently Asked Questions
What does Abbott Laboratories do? ▼
Abbott Laboratories is a Medical Devices company operating in the Healthcare sector. The company is headquartered in Abbott Park, United States.
What sector is ABT in? ▼
ABT operates in the Healthcare sector, specifically in the Medical Devices industry.
When did ABT go public? ▼
Abbott Laboratories went public in 1980, making it a 46-year-old public company as of 2026.
How much would $1,000 invested in ABT 5 years ago be worth today? ▼
A $1,000 investment in ABT five years ago would be worth approximately $1,020 today, representing a 2.0% return.
Does ABT pay dividends? ▼
Yes, Abbott Laboratories pays a dividend with a current yield of 2.33%, which is $2.52 per share annually.
What is ABT's market cap? ▼
Abbott Laboratories has a market capitalization of $188 billion, classifying it as a large-cap company.
What is ABT's P/E ratio? ▼
ABT has a trailing P/E ratio of 29.0 and a forward P/E of 17.3, which measures how much investors are paying per dollar of earnings.
Is ABT a buy, hold, or sell? ▼
Based on 25 opinions, ABT has a consensus "buy" rating. The average price target is $132.64.
Last updated: 3/14/2026